The global bioreactor market size reached US$ 6.5 Billion in 2022. Looking forward, the publisher expects the market to reach US$ 13.2 Billion by 2028, exhibiting a growth rate (CAGR) of 12.1% during 2023-2028.
A bioreactor refers to a fermentation vessel, wherein biological reactions are executed for developing enzymes and various organisms, including bacteria, animal cells and yeast, under controlled conditions. It aids in producing several pharmaceuticals, such as vaccines and monoclonal antibodies, maintaining the inhomogeneous state of the cells to obtain the desired output, and monitoring the environmental conditions for promoting the cell formation process. On account of these properties, a bioreactor is extensively used by biopharmaceutical companies, research and development (R&D) institutions, and contract research organizations (CROs). At present, it is commercially available in glass, stainless steel, and single-use material types.
A bioreactor refers to a fermentation vessel, wherein biological reactions are executed for developing enzymes and various organisms, including bacteria, animal cells and yeast, under controlled conditions. It aids in producing several pharmaceuticals, such as vaccines and monoclonal antibodies, maintaining the inhomogeneous state of the cells to obtain the desired output, and monitoring the environmental conditions for promoting the cell formation process. On account of these properties, a bioreactor is extensively used by biopharmaceutical companies, research and development (R&D) institutions, and contract research organizations (CROs). At present, it is commercially available in glass, stainless steel, and single-use material types.
Bioreactor Market Trends:
The global bioreactor market is majorly driven by the increasing prevalence of various chronic diseases, such as cancer and diabetes, especially amongst the steadily rising geriatric population. In line with this, the growing need for preventive vaccines, particularly during the sudden outbreak of the coronavirus disease (COVID-19) pandemic, have prompted several pharmaceutical companies to considerably invest in research and development (R&D) activities to extend their production capacities. This, in turn, is inflating the overall sales of bioreactors across the globe. Additionally, significant technological advancements, such as the introduction of single-use bioreactors (SUBs) for optimizing the quality, flexibility, and scalability of microorganisms’ formation operations with minimal cost and energy requirements, are positively stimulating the market growth. Apart from this, increasing biopharmaceuticals manufacturing capacities across developing nations, along with the rising demand for bioreactors that support modern, evolving, high-cell density, and intensified clinical processes requiring high oxygen transfer and great carbon dioxide (CO2) removal are propelling the market growth. Other factors, such as rapid expansion in the pharmaceutical and biologics sectors, the escalating need for effective treatment drugs, and the increasing awareness among consumers regarding the formulation and availability of personalized medicines, are contributing to the market growth significantly.Key Market Segmentation:
The publisher provides an analysis of the key trends in each sub-segment of the global bioreactor market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, usage, scale and control type.Breakup by Type:
- Glass
- Stainless Steel
- Single-Use
Breakup by Usage:
- Lab-Scale Production
- Pilot-Scale Production
- Full-Scale Production
Breakup by Scale:
- 5L-20L
- 20L-200L
- 200L-1500L
- Above 1500L
Breakup by Control Type:
- Manual
- Automated
Breakup by Region:
North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
Latin America
- Brazil
- Mexico
- Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being 2mag AG, bbi-biotech GmbH, Bioengineering AG, Eppendorf SE, Getinge AB, Infors AG, Merck KGaA, Pall Corporation (Danaher Corporation), Sartorius AG, Solaris Biotechnology Srl and Thermo Fisher Scientific Inc.Key Questions Answered in This Report:
- What was the size of the global bioreactor market in 2022?
- What is the expected growth rate of the global bioreactor market during 2023-2028?
- What are the key factors driving the global bioreactor market?
- What has been the impact of COVID-19 on the global bioreactor market?
- What is the breakup of the global bioreactor market based on the type?
- What is the breakup of the global bioreactor market based on the usage?
- What is the breakup of the global bioreactor market based on the control type?
- What are the key regions in the global bioreactor market?
- Who are the key players/companies in the global bioreactor market?
Table of Contents
1 Preface3 Executive Summary12 Value Chain Analysis14 Price Analysis
2 Scope and Methodology
4 Introduction
5 Global Bioreactor Market
6 Market Breakup by Type
7 Market Breakup by Usage
8 Market Breakup by Scale
9 Market Breakup by Control Type
10 Market Breakup by Region
11 SWOT Analysis
13 Porters Five Forces Analysis
15 Competitive Landscape
List of Figures
List of Tables
Companies Mentioned
- 2mag AG
- bbi-biotech GmbH
- Bioengineering AG
- Eppendorf SE
- Getinge AB
- Infors AG
- Merck KGaA
- Pall Corporation (Danaher Corporation)
- Sartorius AG
- Solaris Biotechnology Srl and Thermo Fisher Scientific Inc.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 134 |
| Published | May 2023 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value ( USD | $ 6.5 Billion |
| Forecasted Market Value ( USD | $ 13.2 Billion |
| Compound Annual Growth Rate | 12.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
